Yock Young Dan

Dan Yock Young

  • Associate Professor, Department of┬áMedicine
  • Adjunct, Cancer Science Institute of Singapore, National University of Singapore
  • Senior Consultant, Division of Gastroenterology and Hepatology, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Chair, University Medicine Cluster, National University Health System
  • Head, Department of Medicine, NUS Yong Loo Lin School of Medicine
Joint Appointment(s)
  • Associate Faculty, Genome Institute of Singapore, A*STAR
Academic Qualifications
  • MBBS, National University of Singapore, Singapore
  • MMed (Int Med), National University of Singapore, Singapore
  • MRCP, Royal College of Physicians, United Kingdom
  • FAMS (Gastroenterology), Academy of Medicine, Singapore
  • PhD, National University of Singapore, Singapore
Research Interest(s)
  • Liver Stem Cells
  • Liver Cancer
  • Fatty Liver
Recent Publications
  • 1. Dan YY, Ferrante SA, Elbasha EH, Hsu TY. 2015. Cost-effectiveness of boceprevir co-administration versus pegylated interferon-╬▒2b and ribavirin only for patients with hepatitis C genotype 1 in Singapore. Antivir Ther. 20(2):209-16. doi: 10.3851/IMP2825. 25105844.
  • 2. Lo AO, Wong VW, Wong GL, Chan HL, Dan YY. 2015 Feb. Cost effectiveness of response-guided therapy with peginterferon in the treatment of chronic hepatitis B. Clin Gastroenterol Hepatol. 13(2):377-385.e5. doi: 10.1016/j.cgh.2014.06.022. 24993366.
  • 3. Tan CY, Lai RC, Wong W, Dan YY, Lim SK, Ho HK. 2014 Jun. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 5(3):76. doi: 10.1186/scrt465. 24915963.
  • 4. Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, Ravikumar S, Srivastava S, Tian X, Poon RT, Fan ST, Luk JM, Dan YY, Salto-Tellez M, Chai L, Tenen DG. 2013 Jun. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 368(24):2266-76. doi: 10.1056/NEJMoa1300297. 23758232.
  • 5. Hartono JL, Aung MO, Dan YY, Gowans M, Lim K, Lee YM, Lee GH, Low HC, Tan PS, Thwin MA, Soon C, Chiu LL, Khoo MJ, Koay E, Lim SG. 2013 Apr. Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B. Aliment Pharmacol Ther. 37(7):710-9. doi: 10.1111/apt.12251. 23432107.